Special Issue "Antibody Conjugates"
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (31 January 2012)
Dr. Surinder K Sharma
ADEPT & Translational Therapeutics, Cancer Institute, School of Life and Medical Sciences,University College London, London WC1E 6BT, UK
Interests: antibody; enzyme; drug; prodrug; antibody-enzyme conjugates; antibody-enzyme fusion proteins; immunogenicity
Article: Poly(ethylene glycol)-Lipid-Conjugated Antibodies Enhance Dendritic Cell Phagocytosis of Apoptotic Cancer Cells
Pharmaceuticals 2012, 5(5), 405-416; doi:10.3390/ph5050405
Received: 8 February 2012; in revised form: 27 March 2012 / Accepted: 17 April 2012 / Published: 26 April 2012| Download PDF Full-text (774 KB) | View HTML Full-text | Download XML Full-text
Article: Pre-Clinical Assessment of 177Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease
Pharmaceuticals 2012, 5(1), 1-15; doi:10.3390/ph5010001
Received: 4 November 2011; in revised form: 6 December 2011 / Accepted: 14 December 2011 / Published: 22 December 2011| Download PDF Full-text (422 KB) | View HTML Full-text | Download XML Full-text
Last update: 4 March 2014